- Home
- IMPP vs CLYM Comparison
IMPP vs CLYM Comparison
Compare IMPP & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMPP
- CLYM
- Stock Information
- Founded
- IMPP 1981
- CLYM 2018
- Country
- IMPP Greece
- CLYM United States
- Employees
- IMPP N/A
- CLYM N/A
- Industry
- IMPP Marine Transportation
- CLYM
- Sector
- IMPP Consumer Discretionary
- CLYM
- Exchange
- IMPP Nasdaq
- CLYM NYSE
- Market Cap
- IMPP 99.2M
- CLYM 101.6M
- IPO Year
- IMPP N/A
- CLYM 2021
- Fundamental
- Price
- IMPP $2.44
- CLYM $1.21
- Analyst Decision
- IMPP
- CLYM
- Analyst Count
- IMPP 0
- CLYM 0
- Target Price
- IMPP N/A
- CLYM N/A
- AVG Volume (30 Days)
- IMPP 127.4K
- CLYM 168.2K
- Earning Date
- IMPP 05-15-2025
- CLYM 05-14-2025
- Dividend Yield
- IMPP N/A
- CLYM N/A
- EPS Growth
- IMPP N/A
- CLYM N/A
- EPS
- IMPP 1.40
- CLYM N/A
- Revenue
- IMPP $147,479,980.00
- CLYM N/A
- Revenue This Year
- IMPP $3.05
- CLYM N/A
- Revenue Next Year
- IMPP $47.92
- CLYM N/A
- P/E Ratio
- IMPP $1.75
- CLYM N/A
- Revenue Growth
- IMPP N/A
- CLYM N/A
- 52 Week Low
- IMPP $2.23
- CLYM $1.18
- 52 Week High
- IMPP $4.59
- CLYM $11.55
- Technical
- Relative Strength Index (RSI)
- IMPP 39.85
- CLYM N/A
- Support Level
- IMPP $2.35
- CLYM N/A
- Resistance Level
- IMPP $2.60
- CLYM N/A
- Average True Range (ATR)
- IMPP 0.08
- CLYM 0.00
- MACD
- IMPP 0.01
- CLYM 0.00
- Stochastic Oscillator
- IMPP 36.00
- CLYM 0.00
About IMPP Imperial Petroleum Inc.
Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil and jet fuel, as well as edible oils and chemicals.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.